MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-04-2026
Smith & Nephew plc Operating Expenses 2011-2026 | SNN
Annual Operating Expenses Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 2.67 B | 2.81 B | 2.6 B | 2.56 B | 2.5 B | 2.6 B | 2.56 B | 2.37 B | 2.15 B | 2.27 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.81 B | 2.15 B | 2.51 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 186.84 | 3.42 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 34.25 | 2.33 % | $ 1.58 B | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.72 | 3.21 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 292.65 | 1.55 % | $ 8.26 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | 0.59 % | $ 17.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.24 | -2.56 % | $ 121 M |  France |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 40.19 | 2.92 % | $ 5.99 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 64.09 | 1.44 % | $ 94.9 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 6.07 | 2.45 % | $ 72.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 10.32 | 3.1 % | $ 292 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.32 | 1.48 % | $ 214 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.78 | 6.19 % | $ 32.6 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.42 | -0.54 % | $ 171 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.88 | 0.17 % | $ 7.99 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
547 M | $ 95.81 | 3.04 % | $ 13 B | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 349.15 | 0.55 % | $ 133 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.0 | -1.48 % | $ 1.22 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.43 | 3.62 % | $ 938 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 24.7 | 1.88 % | $ 565 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 115.77 | 2.13 % | $ 3.94 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.72 | 4.54 % | $ 416 M | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 20.64 | 2.69 % | $ 1.4 B | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.78 | 3.16 % | $ 386 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 56.6 | 3.06 % | $ 1.66 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 39.46 | 2.6 % | $ 1.22 B | USA |